Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000721748-13-000565
Filing Date
2013-08-28
Accepted
2013-08-28 16:45:41
Documents
10
Period of Report
2013-02-28

Document Format Files

Seq Description Document Type Size
1 gbiq10q022813a.htm 10-Q 117459
2 CERTIFICATIONS gbiq311.htm EX-31.1 6329
3 gbiq312.htm EX-31.2 6636
4 CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTIONS 1350 AS ADOPTED PURSUANT TO SECTIO gbiq321.htm EX-32.1 3160
  Complete submission text file 0000721748-13-000565.txt   1684830

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gbiq-20130228.xml EX-101.INS 73954
6 XBRL SCHEMA FILE gbiq-20130228.xsd EX-101.SCH 17034
7 XBRL CALCULATION FILE gbiq-20130228_cal.xml EX-101.CAL 11837
8 XBRL DEFINITION FILE gbiq-20130228_def.xml EX-101.DEF 18164
9 XBRL LABEL FILE gbiq-20130228_lab.xml EX-101.LAB 98404
10 XBRL PRESENTATION FILE gbiq-20130228_pre.xml EX-101.PRE 81577
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-33271 | Film No.: 131066435
SIC: 7389 Services-Business Services, NEC